Baricitinib in Pediatric Chronic Immune Thrombocytopenia and Associated Autoimmune Conditions: A Case Report

    December 2024 in “ Frontiers in Pediatrics ”
    G. López de Hontanar Torres, Josune Zubicaray, Elena Sebastián, Á. Hernández‐Martín, June Iriondo, Julián Sevilla
    From the encyclopedia
    Baricitinib →

    JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Image
    Studysummary This case report details the first use of baricitinib in a pediatric patient with immune thrombocytopenia and alopecia areata, showing successful treatment with increased platelet counts.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This case report highlights the successful use of baricitinib, a JAK 1/2 inhibitor, in a 16-year-old female with chronic immune thrombocytopenia (cITP) and alopecia areata, where conventional treatments failed. Baricitinib, used off-label, significantly improved platelet counts and alopecia, with sustained normal platelet levels post-treatment. The findings suggest baricitinib as a potential treatment for pediatric cITP with autoimmune conditions, warranting further clinical trials to validate its efficacy.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results